Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis

Hematology. 2020 Dec;25(1):320. doi: 10.1080/16078454.2020.1802931.
No abstract available

MeSH terms

  • Adult
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / transmission
  • Coronavirus Infections / virology
  • Cough / diagnosis
  • Cough / physiopathology
  • Cough / virology
  • Cyclophosphamide / therapeutic use
  • Dyspnea / diagnosis
  • Dyspnea / physiopathology
  • Dyspnea / virology
  • Female
  • Fever / diagnosis
  • Fever / physiopathology
  • Fever / virology
  • Headache / diagnosis
  • Headache / physiopathology
  • Headache / virology
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Mexico
  • Middle Aged
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / therapy*
  • Multiple Sclerosis / virology
  • Myeloablative Agonists / therapeutic use
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / transmission
  • Pneumonia, Viral / virology
  • Risk
  • Rituximab / therapeutic use
  • SARS-CoV-2
  • Transplantation Conditioning / methods
  • Transplantation, Autologous

Substances

  • Myeloablative Agonists
  • Rituximab
  • Cyclophosphamide